Dental Bone Graft Substitute Market

The report "Dental Bone Graft Substitutes Market by Type ( Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (sinus Lift, Ridge Augumentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region- Global Forecast to 2029", is projected to reach 1.8 billion in 2029 from USD 1.3 billion in 2024, at a CAGR of 7.7% between 2024 and 2029.

Browse 248 market data Tables and 56 Figures spread through 273 Pages and in-depth TOC on "Dental Bone Graft Substitutes Market by Type ( Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (sinus Lift, Ridge Augumentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region- Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.html

The global population is growing older, leading to an increased demand for dental bone graft substitute also the increasing popularity of dental implants as a tooth replacement option creates a direct need for bone graft substitutes which is expected to drive the market growth. However, high material costs and surgical costs associated with hospital or clinic fees, surgeon fees, and anesthesia is expected to challenge the growth of the market.

This report divides dental bone graft substitute into four segments – type, application, mechanism, product, end user and region.

“Based on dental bone graft substitute by end user, the hospitals segment is expected to grow at the highest CAGR during the forecast period.”

Under end user, hospital segment is forecasted to grow at the highest CAGR from 2024 to 2029., Bone grafting is frequently used in hospitals for oral and maxillofacial surgery for procedures like jaw reconstruction, alveolar ridge preservation, cleft lip and palate repair and dental implantology, when natural jawbone is insufficient for implant placement, bone grafts provide a foundation for successful implant osseointegration (fusion with bone).

“The bio OSS segment is expected to account for the largest share, by product in dental bone graft substitute.”

By product segment, dental bone graft substitute is segmented into bio OSS, osteograf, grafton and others. Bio-Oss accounts for the largest share in by product category. Bio-Oss has a long history of successful use in dental bone grafting procedures, with extensive clinical research supporting its efficacy and safety which is expected to drive the segment growth.

“The osteoconduction segment is expected to account for the largest share, by mechanism in dental bone graft substitute.”

By mechanism segment, dental bone graft substitute is segmented into bio osteoconduction, osteoinduction, osteopromotion, osteogenesis. osteoconduction accounts for the largest share in by mechanism category. Osteoconduction promotes bone regeneration at the defect site, provides a foundation for dental implant placement and supports jawbone structure and prevents collapse which is expected to drive the segment growth.

“In 2023, Europe was the region with the second largest market share in dental bone graft substitute“

Dental bone graft substitute is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa and GCC countries

Europe accounted for the second-largest share of dental bone graft substitute in 2023. The apidly aging population, leading to a higher demand for dental bone graft substitute is driving the growth of dental bone graft substitute in the European region.

Key players in dental bone graft substitute include Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Institut Straumann AG (Switzerland),  Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health (US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd. (Japan), BEGO GmbH & Co. KG (Germany), Young Innovations (US), Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC (US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox International Corp.(Taiwan), Meyer Haake GMBH (Germany) and  Arora Biosurgery Ltd. (New Zealand).

Don’t miss out on business opportunities in Dental Bone Graft Substitutes Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]